Analytical Data
-
基因名
Tachylectin
- Application
-
别名
Lectin L10c
-
种属
Tachypleus tridentatus
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q27084
-
表达区间
20-255aa
-
分子量
42.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Tachylectins are a group of lectins originally identified in the horseshoe crab (Limulus polyphemus) known for their ability to bind to specific carbohydrates and play a crucial role in the innate immune response. Due to their unique properties, including antimicrobial activity and the ability to recognize pathogen-associated molecular patterns, tachylectins have garnered significant interest in biomedical research. The recombinant production of tachylectin proteins in various expression systems allows for in-depth studies of their structure-function relationships and potential therapeutic applications. Understanding the mechanisms by which tachylectins interact with pathogens can lead to advancements in drug development, particularly in the creation of novel antimicrobial agents or immune modulators. Additionally, tachylectins have potential applications in biosensing technologies due to their specificity in binding, making them valuable tools in diagnostics and clinical research. Studies focusing on the recombinant expression, purification, and functional characterization of tachylectin proteins are essential to explore their roles and applications more comprehensively, laying the groundwork for future innovations in treatment and diagnostic strategies against infectious diseases.
